Rockwell Medical (RMTI) Other Non Operating Income (2017 - 2026)
Rockwell Medical's (RMTI) quarterly Other Non Operating Income came in at -$125000.0 in Q1 2026, up 19.35% YoY from -$104729.7 in Q1 2025, and up 19.87% on a QoQ basis from -$156000.0 in Q4 2025.
Rockwell Medical (RMTI) Other Non Operating Income (2017 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 10 years of Other Non Operating Income data on file, last reported at -$125000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 19.35% year-over-year to -$125000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$593000.0 (up 29.07% YoY) and the FY2025 annual result came in at -$623000.0, up 42.74% from the prior year.
- Other Non Operating Income climbed to -$125000.0 in Q1 2026, from -$156000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of -$125000.0 in Q1 2026 to a low of -$965000.0 in Q4 2023.
- A 5-year average of -$323764.7 and a median of -$272000.0 in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income plunged 143.69% — and 2024, when it surged 75.44%.
- Tracing RMTI's Other Non Operating Income over 5 years: stood at -$396000.0 in 2022, then sank by 143.69% to -$965000.0 in 2023, then surged by 75.44% to -$237000.0 in 2024, then soared by 34.18% to -$156000.0 in 2025, then climbed by 19.87% to -$125000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$125000.0 (Q1 2026), -$156000.0 (Q4 2025), and -$169000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Rockwell Medical | 29.69 Mn | 4.89 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -111,000.00 |
| Mar 31, 2026 | -125,000.00 |
| Dec 31, 2025 | -156,000.00 |
| Sep 30, 2025 | -169,000.00 |
| Jun 30, 2025 | -143,000.00 |
| Mar 31, 2025 | -155,000.00 |
| Dec 31, 2024 | -237,000.00 |
| Sep 30, 2024 | -272,000.00 |
| Jun 30, 2024 | -172,000.00 |
| Mar 31, 2024 | -407,000.00 |
| Dec 31, 2023 | -965,000.00 |
| Sep 30, 2023 | -135,000.00 |
| Jun 30, 2023 | -346,000.00 |
| Mar 31, 2023 | -323,000.00 |
| Dec 31, 2022 | -396,000.00 |
| Sep 30, 2022 | -482,000.00 |
| Jun 30, 2022 | -485,000.00 |
| Mar 31, 2022 | -536,000.00 |
| Dec 31, 2021 | -582,000.00 |
| Sep 30, 2021 | -609,000.00 |